• Cibus welcomed new EU rules that treat crops improved without foreign DNA like conventionally bred crops, not transgenic GMOs.
• The shift opens a regulatory pathway in Europe for Cibus’ non-transgenic gene-edited traits, supporting faster commercialization with seed partners.
• Management framed the decision as science-based validation of its approach, citing potential to cut chemical use via traits such as disease resistance.
• Cibus expects the EU move to influence other jurisdictions, building on progress in the UK, where it completed field trials in oilseed rape.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cibus Inc. published the original content used to generate this news brief on June 17, 2026, and is solely responsible for the information contained therein.